Cost-Effectiveness of Regular Surveillance Versus Endoscopy at Need for Patients With Barrett’s Esophagus: Economic Evaluation Alongside the Barrett’s Oesophagus Surveillance Study (BOSS) Randomized Controlled Trial
Authors:
Open Access
- 16 May 2025
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 169 (6) , 1244-1252.e7
Abstract
No abstract availableKeywords
Funding Information
- Health Technology Assessment Programme
This publication has 28 references indexed in Scilit:
- Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial dataeClinicalMedicine, 2021
- Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett’s EsophagusGastroenterology Clinics of North America, 2015
- Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagusGastrointestinal Endoscopy, 2014
- Cause-Specific Mortality of People With Barrett's Esophagus Compared With the General Population: A Population-Based Cohort StudyGastroenterology, 2013
- American Gastroenterological Association Technical Review on the Management of Barrett's EsophagusGastroenterology, 2011
- Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysisGastrointestinal Endoscopy, 2008
- Surveillance of Barrett’s oesophagus: Is it worthwhile?European Journal of Cancer, 2008
- Dysplasia and Cancer in a Large Multicenter Cohort of Patients With Barrett’s EsophagusClinical Gastroenterology and Hepatology, 2006
- Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux diseaseClinical Gastroenterology and Hepatology, 2004
- Medical decision analysis of endoscopic surveillance of Barrett’s oesophagus to prevent oesophageal adenocarcinomaAlimentary Pharmacology & Therapeutics, 2002